Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
2010 StandoutScience
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
2011 StandoutScience
Diversity of the Human Intestinal Microbial Flora
2005 StandoutScience
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
2017
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
1998 Standout
Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease
2002
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
1987
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.
1987
Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.
1988
Resolution of Inflammation in Murine Autoimmune Arthritis Is Disrupted by Cyclooxygenase-2 Inhibition and Restored by Prostaglandin E2-Mediated Lipoxin A4 Production
2010
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
1997 StandoutNature
The mucosal firewalls against commensal intestinal microbes
2009
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats
2003
Inflammation and cancer
2002 StandoutNature
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Piroxicam-??-Cyclodextrin
1994
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation
2006
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria
2005
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?
2009
Intestinal permeability and complications in liver cirrhosis: A prospective cohort study
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease
2000
Mechanism of Action of Anti-Inflammatory Drugs
1996
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Adherent-Invasive Escherichia coli Induce Claudin-2 Expression and Barrier Defect in CEABAC10 Mice and Crohnʼs Disease Patients§
2011
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
2002
Investigation of a role for reduction in ferric iron uptake by mouse duodenum
1992
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
2011
IgA Adaptation to the Presence of Commensal Bacteria in the Intestine
2006
MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis
2005
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Guidelines for the management of inflammatory bowel disease in adults
2011
Chemotactic peptides
1988
Intestinal Permeation and Gastrointestinal Disease
2002
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
2000
Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury
1996
Crohn's disease--a permeability disorder of the tight junction?
1988
Layers of mutualism with commensal bacteria protect us from intestinal inflammation
2006
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
1991
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
2010
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Microbial translocation, immune activation, and HIV disease
2012
Intestinal permeability in gastrointestinal disorders
1990
Increased Intestinal Permeability to (51 Cr) EDTA Is Correlated with IgA Immune Complex‐Plasma Levels in Children with IgA‐Associated Nephropathies
1988
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides
2002
Methods to determine intestinal permeability and bacterial translocation during liver disease
2015
IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms
2001
Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn’s Disease
2012
Pathological bacterial translocation in liver cirrhosis
2013
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
Nanoporous Carbohydrate Metal–Organic Frameworks
2011 StandoutNobel
Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria
2002
Microbial Influences in Inflammatory Bowel Diseases
2008
Inflammatory Bowel Disease
1991 Standout
Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease
1990
Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
2005
Ulcerative colitis
2012 Standout
Leaky Gut in Alcoholic Cirrhosis: A Possible Mechanism for Alcohol-Induced Liver Damage
1999
Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats
1998
Pathogenic Yersinia DNA Is Detected in Bowel and Mesenteric Lymph Nodes From Patients With Crohn's Disease
2003
Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease
1990
Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis
1992
Antiinflammatory Effects of Enterically Coated Amoxicillin-Clavulanic Acid in Active Ulcerative Colitis
1998
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
1993
Intestinal permeability during chemotherapy for childhood tumours
1988
Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy
1992
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged sword
1995
Current concepts of celiac disease pathogenesis
2000
NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects
1997
Mechanisms of NSAID-Induced Gastroenteropathy
1990
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.
1996
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
2015
Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge.
1990
Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens
2002
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
2006
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin
1993
Famotidine for the Prevention of Gastric and Duodenal Ulcers Caused by Nonsteroidal Antiinflammatory Drugs
1996
Gut flora in health and disease
2003 Standout
BLOOD AND PROTEIN LOSS VIA SMALL-INTESTINAL INFLAMMATION INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
1987
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
2004
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
2004
β-Defensin production by human colonic plasma cells: A new look at plasma cells in ulcerative colitis
2007
Increased intestinal permeability in malnourished patients with liver cirrhosis
2012
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Structural and Morphometric Analysis of Murine Small Intestine after Indomethacin Administration
1993
Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis
2001
Intestinal iron absorption studies in mouse models of iron‐overload
1994
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
2009
A guideline for the treatment and prevention of NSAID-induced ulcers
1998
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
Studies of intestinal lymphoid tissue
1989
51Cr-Ethylenediaminetetraacetic Acid Absorption Test: Effects of Naproxen, a Non-Steroidal, Antiinflammatory Drug
1990
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
2001
Coeliac disease: dissecting a complex inflammatory disorder
2002
Gastrointestinal dysfunction in liver cirrhosis
2014
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
2012
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†
2009
Points of control in inflammation
2002 StandoutNature
Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naïve Ulcerative Colitis During Active and Quiescent Disease
2008
Intestinal microbiota: Shaping local and systemic immune responses
2011
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
2000
COX-2 inhibitors
1999 Standout
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
2016
Environmental enteropathy: critical implications of a poorly understood condition
2012
Ethanol metabolism and its effects on the intestinal epithelial barrier
2013
Polymers and Sulfur: what are Organic Polysulfides Good For? Preparative Strategies and Biological Applications
2009
Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites
2008
Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome
2007
Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen
1999
Genetic insights into common pathways and complex relationships among immune-mediated diseases
2013
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Studies of intestinal lymphoid tissue. XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in celiac sprue
1989
Intestinal permeability.
1994
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2006
Computational Design of an α-Gliadin Peptidase
2012 StandoutNobel
Gastrointestinal Complications Associated with Intramuscular Ketorolac Tromethamine Therapy in the Elderly
1995
Structural Basis for Gluten Intolerance in Celiac Sprue
2002 StandoutScience
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
2010
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora
2002 StandoutScienceNobel
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Catalytic Enantioselective Conversion of Epoxides to Thiiranes
2016 StandoutNobel
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice
1998
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
2004 StandoutNobel
Molecular Basis of Celiac Disease
2000
Transglutaminase-Catalyzed Site-Specific Conjugation of Small-Molecule Probes to Proteins in Vitro and on the Surface of Living Cells
2006
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
2012
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
2001
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice
2001
Large intestine permeability is increased in patients with compensated liver cirrhosis
2013
A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis
1998
Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases
1989
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
NSAIDs, Cox-2 inhibitors, and the gut
1995
A mouse model for beta 0-thalassemia.
1995 StandoutNobel
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans
1987
Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis
2009
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
2002
Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage
1996
Microbial Translocation Across the GI Tract
2012
Gut Microbiota and Host Reaction in Liver Diseases
2015
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase
2001
Glucose and citrate reduce the permeability changes caused by indomethacin in humans
1992
Increased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives
1986
Effect of immunologic reactions on rat intestinal epithelium
1988
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy
1987
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of Ingvar Bjarnason being referenced
Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.
1992
Studies of intestinal lymphoid tissue. XIV--HLA status, mucosal morphology, permeability and epithelial lymphocyte populations in first degree relatives of patients with coeliac disease.
1990
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.
1995
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.
1986
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
1991
Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine
1997
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea
1999
Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
1990
In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease.
1984
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen
2001
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis.
1985
Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures
1988
The Pathogenesis and Consequence of Non Steroidal Anti-Inflammatory Drug Induced Small Intestinal Inflammation in Man
1987
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability
1989
Gastroprotection and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1992
Effect of Prostaglandin on Indomethacin-Induced Increased Intestinal Permeability in Man
1989
Sulphasalazine in ulcerative colitis: in memoriam?
1991
Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.
1989
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
2017
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
The Changing Gastrointestinal Side Effect Profile of Non-Steroidal Anti-Inflammatory Drugs: A New Approach for the Prevention of a New Problem
1989
NSAIDs, Cox-2 inhibitors, and the gut
1995
THE PREVENTION AND HEALING OF ACUTE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-ASSOCIATED GASTRODUODENAL MUCOSAL DAMAGE BY MISOPROSTOL
1993
Intestinal inflammation, ileal structure and function in HIV
1996
Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with Leukocytes
2003
Helping the mucosa make sense of macromolecules.
1987
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans
1998
Intestinal permeability in cirrhotic patients with and without ascites
2005
Vindaloo and you.
1988
Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis
1995
Intestinal Absorption and Permeability in Paediatric Short-Bowel Syndrome: A Pilot Study
1999
Intestinal permeability: An overview
1995
A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland
2007
Intestinal permeability in the pathogenesis of NSAID-induced enteropathy
2009
NSAIDs: the Emperor’s new dogma?
2003
Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives?
2003
A Randomized, Double-Blind, Crossover Comparative Endoscopy Study on the Gastroduodenal Tolerability of a Highly Specific Cyclooxygenase-2 Inhibitor, Flosulide, and Naproxen
1997
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
2002
The G.U.T. of gut
2004
Intestinal Permeability to <sup>51</sup>Cr-Labelled Ethylenediaminetetraacetate in Food-Intolerant Subjects
1989
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice
2002
Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs.
1988
In vitro measurement and adaptive response of Fe3+ uptake by mouse intestine
1987
Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
1993
Prevalence and Mechanism of Nonsteroidal Anti-Inflammatory Drug–Induced Clinical Relapse in Patients With Inflammatory Bowel Disease
2006
Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease
1985
INTESTINAL PERMEABILITY AND INFLAMMATION IN RHEUMATOID ARTHRITIS: EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
1984
Systematic review: bile acids and intestinal inflammation‐luminal aggressors or regulators of mucosal defence?
2015
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
1996
Coeliac syndrome: biochemical mechanisms and the missing peptidase hypothesis revisted.
1984
THE LEAKY GUT OF ALCOHOLISM: POSSIBLE ROUTE OF ENTRY FOR TOXIC COMPOUNDS
1984
Effect of Non-Steroidal Anti-Inflammatory Drugs on the Human Small Intestine
1986
Intestinal Permeability: Clinical Correlates
1986
Uses and Abuses of Intestinal Permeability Measurements
1988
Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy.
1985
Intestinal permeability in patients with atopic eczema
1985
A PERSISTENT DEFECT IN INTESTINAL PERMEABILITY IN COELIAC DISEASE DEMONSTRATED BY A 51Cr-LABELLED EDTA ABSORPTION TEST
1983
Absorption of 151chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease
1983
Critical analysis of the accuracy of a combined test ( 75 Se-HCAT and 58 Co-B 12 ) of ileal function using a whole-body counter
1987
Intestinal permeability in patients with Crohn's disease and their first degree relatives.
1992